InterCure Ltd. (TASE:INCR) entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd on January 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,188 ILa | -3.02% | -1.57% | +156.53% |
01/05 | InterCure Ltd. Provides Revenue Guidance for the Full Year 2024 | CI |
01/05 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+156.53% | 150M | |
-.--% | 339M | |
+34.02% | 277M | |
+33.33% | 261M | |
+39.53% | 182M | |
-33.33% | 137M | |
+50.41% | 136M | |
-28.57% | 121M | |
-7.69% | 80.3M | |
+100.00% | 60.26M |
- Stock Market
- Equities
- INCR Stock
- News InterCure Ltd.
- InterCure Ltd. entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd.